San Diego, California based Dexcom to enter EMEA markets through Edinburgh headquarter creating 60 new jobs over three-year period.
With the new EMEA headquarter, Dexcom will be able to reach more than 400 million diabetic patients worldwide. In Scotland itself more than 25 percent of a million population is affected by diabetes. The breakdown of that number suggest that around 13 percent are type 1 and 87 percent are type 2 patients.
WHO claims that the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. The global prevalence of diabetes among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014. It is one of the largest global health emergencies of the 21st century.
Founded in 1999 in San Diego, California, United States, Dexcom makes devices that help in continuous glucose monitoring (CGM) for patients with diabetes. Dexcom devices have a CGM sensor that sits just below the skin’s surface and is attached to a transmitter that wirelessly transfers real-time glucose levels to mobile applications via blue-tooth technology.